Cosmo Bio Company,Limited (TYO:3386)

Cosmo Bio Company,Limited Revenue

Cosmo Bio Company,Limited had revenue of 2.58B JPY in the quarter ending June 30, 2026, with 11.87% growth. This brings the company's revenue in the last twelve months to 11.28B, up 9.39% year-over-year. In the year 2025, Cosmo Bio Company,Limited had annual revenue of 10.77B with 7.26% growth.

• Revenue (ttm): 11.28B
• Revenue Growth: +9.39%
• P/S Ratio: 0.62
• Revenue / Employee: 61.97M
• Employees: 182
• Market Cap: 7.03B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	10.77B	729.00M	7.26%
Dec 31, 2024	10.04B	697.00M	7.46%
Dec 31, 2023	9.34B	-213.00M	-2.23%
Dec 31, 2022	9.55B	322.00M	3.49%
Dec 31, 2021	9.23B	1.14B	14.08%

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 16, 2026

Data Sources Report a data error